Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Consolidated Net Income: 2017-2024

Historic Consolidated Net Income for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to -$24.4 million.

  • DiaMedica Therapeutics' Consolidated Net Income fell 26.40% to -$2.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$10.6 million, marking a year-over-year decrease of 85.72%. This contributed to the annual value of -$24.4 million for FY2024, which is 26.12% down from last year.
  • DiaMedica Therapeutics' Consolidated Net Income amounted to -$24.4 million in FY2024, which was down 26.12% from -$19.4 million recorded in FY2023.
  • Over the past 5 years, DiaMedica Therapeutics' Consolidated Net Income peaked at -$12.3 million during FY2020, and registered a low of -$24.4 million during FY2024.
  • In the last 3 years, DiaMedica Therapeutics' Consolidated Net Income had a median value of -$19.4 million in 2023 and averaged -$19.2 million.
  • Data for DiaMedica Therapeutics' Consolidated Net Income shows a maximum YoY plummeted of 41.72% (in 2023) over the last 5 years.
  • Over the past 5 years, DiaMedica Therapeutics' Consolidated Net Income (Yearly) stood at -$12.3 million in 2020, then dropped by 10.58% to -$13.6 million in 2021, then declined by 0.62% to -$13.7 million in 2022, then plummeted by 41.72% to -$19.4 million in 2023, then fell by 26.12% to -$24.4 million in 2024.